Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Thrive Earlier Detection logo — Pioneering Life-Saving Cancer Detection with Advanced Liquid...

Thrive Earlier Detection

Pioneering Life-Saving Cancer Detection with Advanced Liquid Biopsy Solutions

Founded 2019 Venture round Total: $367.00M Biotechnology, Health Care

General Information

Company Name Thrive Earlier Detection
Founded Year 2019
Founders / Decision Makers
Team member
Industries Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Thrive Earlier Detection. To contact Thrive Earlier Detection, visit thrivedetect.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Thrive Earlier Detection compare?

A PDF of Thrive Earlier Detection and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Thrive Earlier Detection soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Thrive Earlier Detection

Thrive Earlier Detection is a healthcare company striving to revolutionize cancer detection through its advanced liquid biopsy solution, CancerSEEK. The company's dedication to integrating earlier cancer detection into routine medical care is reflected in its mission to save lives. Founded in 2019 by Third Rock Ventures, Thrive has garnered financial backing from prominent investors such as Section 32, Casdin Capital, Biomatics Capital, BlueCross BlueShield Venture Partners, The Invus Group, Camden Partners Nexus, Cowin Venture, Exact Sciences, and Gamma3. Thrive's groundbreaking liquid biopsy test, CancerSEEK, is designed to identify multiple cancers in their early stages and is set to form the foundation of the company's comprehensive cancer information platform. The recent Venture Round investment at 01 January 2023 from Curie.Bio reflects the continued support and belief in Thrive's pioneering approach to life-saving cancer detection.

Business keywords: cancer detection, liquid biopsy, early cancer detection, biotech, investment, venture capital, medical innovation, health startup

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
Curie.Bio
Curie.Bio
01 Jan 2023
Series B $257.00M 9
Lux Capital Third Rock Ventures Sands Capital Ventures
Lux Capital, Third Rock Ventures +7
29 Jul 2020
Series A $110.00M -
30 May 2019

Thrive Earlier Detection Alternatives & Competitors

View All Alternatives
Thrive Earlier Detection vs
Exai Bio
Exai Bio United States

Delivering next-generation liquid biopsy platform for the earliest detection and most accurate cance...

22 employees
Biotechnology, Health Care
Thrive Earlier Detection vs
Dxcover
Dxcover

The Future of Cancer Diagnostics

Series A
24 employees
Biotechnology, Health Care
Compare Thrive Earlier Detection vs Dxcover
Thrive Earlier Detection vs
Mercy BioAnalytics, Inc.
Mercy BioAnalytics, Inc. United States

We are making early stage cancer easier to find.

Series B
62 employees
Biotechnology, Health Care
Compare Thrive Earlier Detection vs Mercy BioAnalytics, Inc.
View all alternatives

FAQ About Thrive Earlier Detection

Pioneering Life-Saving Cancer Detection with Advanced Liquid Biopsy Solutions
Thrive Earlier Detection was founded in 2019.
Thrive Earlier Detection operates in Biotechnology and Health Care. Its work centres on cancer detection, liquid biopsy, early cancer detection and biotech.
Thrive Earlier Detection has completed 3 funding rounds, raising a total of $367.00M. The latest funding stage is Venture round.
Top alternatives and competitors to Thrive Earlier Detection include Exai Bio, Dxcover, Mercy BioAnalytics, Inc., Lucence, Amadix. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Thrive Earlier Detection and Exai Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Thrive Earlier Detection, https://bouncewatch.com/company/thrive-earlier-detection, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout